Respiratory Control and Narcotic Effects

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

March 8, 2018

Primary Completion Date

February 9, 2019

Study Completion Date

February 9, 2019

Conditions
Ventilatory DepressionOpioid IntoxicationOpioid Toxicity
Interventions
DIAGNOSTIC_TEST

Ventilatory chemosensitivity

Using this technique, the patient first voluntarily hyperventilates to a PETCO2 value of 20-25 mmHg, then undergoes a rebreathing test allowing the PCO2 to rise to 55-60 mmHg while PETO2 is maintained at 150 mmHg. The procedure is then repeated with PETO2 clamped at 50 mmHg. Parameters derived from this method include slopes of the ventilatory response during hyperoxia and hypoxia.

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Duke University

OTHER

NCT04047550 - Respiratory Control and Narcotic Effects | Biotech Hunter | Biotech Hunter